Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease

• প্রধান লেখক: V. I. Ignatyeva (লেখক), S. V. Moiseev (লেখক), N. M. Bulanov (লেখক), E. A. Karovajkina (লেখক), A S. Moiseev (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: IRBIS LLC, 2019-01-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Fabry disease (FD) is a severe lysosome storage disease caused by congenital deficiency of the enzyme α-galactosidase A and characterized by the risk of renal failure combined with cardiovascular and CNS complications. According to the currently available information, the early start of enzyme repla...